Krystal Biotech Inc. (KRYS)
NASDAQ · Healthcare
Krystal Biotech Inc. Total Liabilities 2020–2025
Krystal Biotech Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Krystal Biotech Inc. total liabilities as of December 31, 2025: 114.2M, a 4.36% increase year-over-year.
- Krystal Biotech Inc. total liabilities for 2025 were 114.2M, a 4.36% increase from 2024.
- Krystal Biotech Inc. total liabilities for 2024 were 109.5M, a 175.62% increase from 2023.
- Krystal Biotech Inc. total liabilities for 2023 were 39.7M, a 9.65% increase from 2022.
- Krystal Biotech Inc. total liabilities for 2022 were 36.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Krystal Biotech Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $114 |
| 2024 | $109 |
| 2023 | $40 |
| 2022 | $36 |
| 2021 | $33 |
| 2020 | $19 |
Krystal Biotech Inc. Total Liabilities — FAQ
Krystal Biotech Inc. (KRYS) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KRYS's total liabilities history?
The chart and table above show Krystal Biotech Inc.'s total liabilities by year and by quarter, including the growth rate.